Skip to main content
Premium Trial:

Request an Annual Quote

Krebs' Nobel on Auction Block

The Nobel Prize awarded to Hans Krebs, of citric acid cycle fame, in 1953 is to be auctioned today by Sotheby's to raise money to support young and refugee researchers, Reuters reports.

Krebs, who fled Nazi Germany in the 1930s to settle in the UK, shared the 1953 Nobel Prize in Physiology or Medicine equally with Fritz Lipmann.

Sotheby's has estimated Krebs' medal to be worth between $385,000 and $462,000. The proceeds of the sale will go to the Sir Hans Krebs Trust, which provides grants to young researchers and refugee researchers working in the biomedical sciences.

"My father was a passionate believer in the importance of training the next generation. I believe that he would have thoroughly approved of the creation of the Trust by the sale of his Medal," Krebs' son John, a member of the British House of Lords, says in a statement, according to Reuters.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.